Ionic Capital Management’s Strata Critical Medical SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-550,000
Closed -$1.42M – 201
2023
Q3
$1.42M Buy
550,000
+150,000
+38% +$527K 0.35% 64
2023
Q2
$1.58M Hold
400,000
– – 0.45% 67
2023
Q1
$1.35M Buy
400,000
+38,200
+11% +$156K 0.39% 61
2022
Q4
$1.3M Hold
361,800
– – 0.31% 85
2022
Q3
$1.46M Hold
361,800
– – 0.2% 126
2022
Q2
$1.61M Sell
361,800
-68,800
-16% -$497K 0.19% 113
2022
Q1
$3.66M Sell
430,600
-178,700
-29% -$1.26M 0.42% 61
2021
Q4
$5.38M Sell
609,300
-88,800
-13% -$844K 0.68% 39
2021
Q3
$7.26M Sell
698,100
-700
-0.1% -$6.12K 0.92% 24
2021
Q2
$7.34M Buy
+698,800
New +$6.9M 0.77% 30

Other funds holding SRTA

Ionic Capital Management's SRTA Position: Q4 2023 in Review

Ionic Capital Management sold out of Strata Critical Medical (SRTA) in Q4 2023, closing a stake of 203,313 shares — an estimated $527K sold.

Ionic Capital Management first reported a position in SRTA in Q2 2022 and held it in 4 quarters. The position peaked at $547K in Q4 2022. 102 funds tracked by Wall St. Rank hold SRTA as of Q4 2023.

  • Ionic Capital Management reported no remaining Strata Critical Medical position as of Q4 2023 after selling out during the quarter.
  • Ionic Capital Management sold 203,313 Strata Critical Medical shares in Q4 2023, an estimated $527K.
  • Ionic Capital Management first reported a position in Strata Critical Medical in Q2 2022 and held it in 4 quarters.
  • Ionic Capital Management's Strata Critical Medical position peaked at $547K in Q4 2022.
  • 102 funds tracked by Wall St. Rank held Strata Critical Medical as of Q4 2023.

Based on Ionic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.